Paraneoplastic Cerebellar Degeneration and Symptomless Lambert–Eaton Myasthenic Syndrome With SOX ‐1 Antibodies

A 62‐year‐old man was diagnosed with paraneoplastic cerebellar degeneration (PCD) at a previous hospital due to cerebellar ataxia, positive serum SOX‐1 antibodies, and small cell lung cancer. Although the tumor has shrunk by chemotherapy, the cerebellar ataxia progressed and left him unable to walk....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology and clinical neuroscience 2024-11
Hauptverfasser: Ohya, Yuichiro, Tokashiki, Takashi, Kuda, Tomoya, Nakachi, Ryo, Tamaki, Kohei, Senoo, Hiroshi, Yasutomi, Daigo, Kido, Miwako, Fujiwara, Yoshihiko, Fujisaki, Natsumi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Neurology and clinical neuroscience
container_volume
creator Ohya, Yuichiro
Tokashiki, Takashi
Kuda, Tomoya
Nakachi, Ryo
Tamaki, Kohei
Senoo, Hiroshi
Yasutomi, Daigo
Kido, Miwako
Fujiwara, Yoshihiko
Fujisaki, Natsumi
description A 62‐year‐old man was diagnosed with paraneoplastic cerebellar degeneration (PCD) at a previous hospital due to cerebellar ataxia, positive serum SOX‐1 antibodies, and small cell lung cancer. Although the tumor has shrunk by chemotherapy, the cerebellar ataxia progressed and left him unable to walk. Lambert–Eaton myasthenic syndrome (LEMS) was suspected, because nerve conduction studies showed that reduced compound muscle action potential amplitudes disproportionate to muscle weakness. PCD‐LEMS with SOX‐1 antibodies was diagnosed on the basis of waxing by high‐frequency repetitive nerve stimulation test and high P/Q‐type voltage‐gated calcium channel antibody levels. Immunoglobulin therapy and 3,4‐diaminopyridine contributed to improved activities of daily living by improving muscle weakness masked by cerebellar symptoms. In patients with SOX‐1 antibodies, investigating for tumors and LEMS is necessary, even if muscle weakness is not noticeable.
doi_str_mv 10.1111/ncn3.12867
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1111_ncn3_12867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1111_ncn3_12867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c120t-60199b0e7b3e34b4543b77177da88bcb491e545e4e98288f4d5cf7c20ac0de163</originalsourceid><addsrcrecordid>eNpNkL1OwzAcxC0EElXpwhN4RkqxYye2xyqUD6moSAXBFtnOPzQocSrbS7Y-AhJv2CchBQZuuZNOd8MPoUtK5nTUtbOOzWkqc3GCJinhKuFUsNN_-RzNQvggo5RiVMkJCk_aawf9rtUhNhYX4MFA22qPb-AdHHgdm95h7Sq8Gbpd7LsWQsAr3Rnw8bD_Wuo49o_DuN-CGy82g6t83wF-beIWb9Zv-LD_pHjhYmP6qoFwgc5q3QaY_fkUvdwun4v7ZLW-eygWq8TSlMQkJ1QpQ0AYBowbnnFmhKBCVFpKYw1XFDKeAQclUylrXmW2FjYl2pIKaM6m6Or31_o-BA91ufNNp_1QUlIeiZVHYuUPMfYNSsthzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Paraneoplastic Cerebellar Degeneration and Symptomless Lambert–Eaton Myasthenic Syndrome With SOX ‐1 Antibodies</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ohya, Yuichiro ; Tokashiki, Takashi ; Kuda, Tomoya ; Nakachi, Ryo ; Tamaki, Kohei ; Senoo, Hiroshi ; Yasutomi, Daigo ; Kido, Miwako ; Fujiwara, Yoshihiko ; Fujisaki, Natsumi</creator><creatorcontrib>Ohya, Yuichiro ; Tokashiki, Takashi ; Kuda, Tomoya ; Nakachi, Ryo ; Tamaki, Kohei ; Senoo, Hiroshi ; Yasutomi, Daigo ; Kido, Miwako ; Fujiwara, Yoshihiko ; Fujisaki, Natsumi</creatorcontrib><description>A 62‐year‐old man was diagnosed with paraneoplastic cerebellar degeneration (PCD) at a previous hospital due to cerebellar ataxia, positive serum SOX‐1 antibodies, and small cell lung cancer. Although the tumor has shrunk by chemotherapy, the cerebellar ataxia progressed and left him unable to walk. Lambert–Eaton myasthenic syndrome (LEMS) was suspected, because nerve conduction studies showed that reduced compound muscle action potential amplitudes disproportionate to muscle weakness. PCD‐LEMS with SOX‐1 antibodies was diagnosed on the basis of waxing by high‐frequency repetitive nerve stimulation test and high P/Q‐type voltage‐gated calcium channel antibody levels. Immunoglobulin therapy and 3,4‐diaminopyridine contributed to improved activities of daily living by improving muscle weakness masked by cerebellar symptoms. In patients with SOX‐1 antibodies, investigating for tumors and LEMS is necessary, even if muscle weakness is not noticeable.</description><identifier>ISSN: 2049-4173</identifier><identifier>EISSN: 2049-4173</identifier><identifier>DOI: 10.1111/ncn3.12867</identifier><language>eng</language><ispartof>Neurology and clinical neuroscience, 2024-11</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c120t-60199b0e7b3e34b4543b77177da88bcb491e545e4e98288f4d5cf7c20ac0de163</cites><orcidid>0000-0003-0656-2752 ; 0000-0002-4124-6192</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Ohya, Yuichiro</creatorcontrib><creatorcontrib>Tokashiki, Takashi</creatorcontrib><creatorcontrib>Kuda, Tomoya</creatorcontrib><creatorcontrib>Nakachi, Ryo</creatorcontrib><creatorcontrib>Tamaki, Kohei</creatorcontrib><creatorcontrib>Senoo, Hiroshi</creatorcontrib><creatorcontrib>Yasutomi, Daigo</creatorcontrib><creatorcontrib>Kido, Miwako</creatorcontrib><creatorcontrib>Fujiwara, Yoshihiko</creatorcontrib><creatorcontrib>Fujisaki, Natsumi</creatorcontrib><title>Paraneoplastic Cerebellar Degeneration and Symptomless Lambert–Eaton Myasthenic Syndrome With SOX ‐1 Antibodies</title><title>Neurology and clinical neuroscience</title><description>A 62‐year‐old man was diagnosed with paraneoplastic cerebellar degeneration (PCD) at a previous hospital due to cerebellar ataxia, positive serum SOX‐1 antibodies, and small cell lung cancer. Although the tumor has shrunk by chemotherapy, the cerebellar ataxia progressed and left him unable to walk. Lambert–Eaton myasthenic syndrome (LEMS) was suspected, because nerve conduction studies showed that reduced compound muscle action potential amplitudes disproportionate to muscle weakness. PCD‐LEMS with SOX‐1 antibodies was diagnosed on the basis of waxing by high‐frequency repetitive nerve stimulation test and high P/Q‐type voltage‐gated calcium channel antibody levels. Immunoglobulin therapy and 3,4‐diaminopyridine contributed to improved activities of daily living by improving muscle weakness masked by cerebellar symptoms. In patients with SOX‐1 antibodies, investigating for tumors and LEMS is necessary, even if muscle weakness is not noticeable.</description><issn>2049-4173</issn><issn>2049-4173</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkL1OwzAcxC0EElXpwhN4RkqxYye2xyqUD6moSAXBFtnOPzQocSrbS7Y-AhJv2CchBQZuuZNOd8MPoUtK5nTUtbOOzWkqc3GCJinhKuFUsNN_-RzNQvggo5RiVMkJCk_aawf9rtUhNhYX4MFA22qPb-AdHHgdm95h7Sq8Gbpd7LsWQsAr3Rnw8bD_Wuo49o_DuN-CGy82g6t83wF-beIWb9Zv-LD_pHjhYmP6qoFwgc5q3QaY_fkUvdwun4v7ZLW-eygWq8TSlMQkJ1QpQ0AYBowbnnFmhKBCVFpKYw1XFDKeAQclUylrXmW2FjYl2pIKaM6m6Or31_o-BA91ufNNp_1QUlIeiZVHYuUPMfYNSsthzw</recordid><startdate>20241124</startdate><enddate>20241124</enddate><creator>Ohya, Yuichiro</creator><creator>Tokashiki, Takashi</creator><creator>Kuda, Tomoya</creator><creator>Nakachi, Ryo</creator><creator>Tamaki, Kohei</creator><creator>Senoo, Hiroshi</creator><creator>Yasutomi, Daigo</creator><creator>Kido, Miwako</creator><creator>Fujiwara, Yoshihiko</creator><creator>Fujisaki, Natsumi</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-0656-2752</orcidid><orcidid>https://orcid.org/0000-0002-4124-6192</orcidid></search><sort><creationdate>20241124</creationdate><title>Paraneoplastic Cerebellar Degeneration and Symptomless Lambert–Eaton Myasthenic Syndrome With SOX ‐1 Antibodies</title><author>Ohya, Yuichiro ; Tokashiki, Takashi ; Kuda, Tomoya ; Nakachi, Ryo ; Tamaki, Kohei ; Senoo, Hiroshi ; Yasutomi, Daigo ; Kido, Miwako ; Fujiwara, Yoshihiko ; Fujisaki, Natsumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c120t-60199b0e7b3e34b4543b77177da88bcb491e545e4e98288f4d5cf7c20ac0de163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohya, Yuichiro</creatorcontrib><creatorcontrib>Tokashiki, Takashi</creatorcontrib><creatorcontrib>Kuda, Tomoya</creatorcontrib><creatorcontrib>Nakachi, Ryo</creatorcontrib><creatorcontrib>Tamaki, Kohei</creatorcontrib><creatorcontrib>Senoo, Hiroshi</creatorcontrib><creatorcontrib>Yasutomi, Daigo</creatorcontrib><creatorcontrib>Kido, Miwako</creatorcontrib><creatorcontrib>Fujiwara, Yoshihiko</creatorcontrib><creatorcontrib>Fujisaki, Natsumi</creatorcontrib><collection>CrossRef</collection><jtitle>Neurology and clinical neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohya, Yuichiro</au><au>Tokashiki, Takashi</au><au>Kuda, Tomoya</au><au>Nakachi, Ryo</au><au>Tamaki, Kohei</au><au>Senoo, Hiroshi</au><au>Yasutomi, Daigo</au><au>Kido, Miwako</au><au>Fujiwara, Yoshihiko</au><au>Fujisaki, Natsumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Paraneoplastic Cerebellar Degeneration and Symptomless Lambert–Eaton Myasthenic Syndrome With SOX ‐1 Antibodies</atitle><jtitle>Neurology and clinical neuroscience</jtitle><date>2024-11-24</date><risdate>2024</risdate><issn>2049-4173</issn><eissn>2049-4173</eissn><abstract>A 62‐year‐old man was diagnosed with paraneoplastic cerebellar degeneration (PCD) at a previous hospital due to cerebellar ataxia, positive serum SOX‐1 antibodies, and small cell lung cancer. Although the tumor has shrunk by chemotherapy, the cerebellar ataxia progressed and left him unable to walk. Lambert–Eaton myasthenic syndrome (LEMS) was suspected, because nerve conduction studies showed that reduced compound muscle action potential amplitudes disproportionate to muscle weakness. PCD‐LEMS with SOX‐1 antibodies was diagnosed on the basis of waxing by high‐frequency repetitive nerve stimulation test and high P/Q‐type voltage‐gated calcium channel antibody levels. Immunoglobulin therapy and 3,4‐diaminopyridine contributed to improved activities of daily living by improving muscle weakness masked by cerebellar symptoms. In patients with SOX‐1 antibodies, investigating for tumors and LEMS is necessary, even if muscle weakness is not noticeable.</abstract><doi>10.1111/ncn3.12867</doi><orcidid>https://orcid.org/0000-0003-0656-2752</orcidid><orcidid>https://orcid.org/0000-0002-4124-6192</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2049-4173
ispartof Neurology and clinical neuroscience, 2024-11
issn 2049-4173
2049-4173
language eng
recordid cdi_crossref_primary_10_1111_ncn3_12867
source Wiley Online Library Journals Frontfile Complete
title Paraneoplastic Cerebellar Degeneration and Symptomless Lambert–Eaton Myasthenic Syndrome With SOX ‐1 Antibodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T12%3A13%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Paraneoplastic%20Cerebellar%20Degeneration%20and%20Symptomless%20Lambert%E2%80%93Eaton%20Myasthenic%20Syndrome%20With%20SOX%20%E2%80%901%20Antibodies&rft.jtitle=Neurology%20and%20clinical%20neuroscience&rft.au=Ohya,%20Yuichiro&rft.date=2024-11-24&rft.issn=2049-4173&rft.eissn=2049-4173&rft_id=info:doi/10.1111/ncn3.12867&rft_dat=%3Ccrossref%3E10_1111_ncn3_12867%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true